Pfizer agrees $10m licensing deal with BioInvent

22-12-2016

Pfizer agrees $10m licensing deal with BioInvent

pio3 / shutterstock.com

Pfizer has agreed a collaboration and licensing agreement with Sweden-based pharmaceutical company BioInvent International on cancer immunotherapy research.


BioInvent International, Pfizer, immuno-regulatory antibodies, cancer, agreement, licence, research

LSIPR